Pediatric Seropositive Autoimmune Encephalitis: A Health Outcome Study
Journal of Visualized Experiments · 2026-11-13 · (237)
DOI: 10.3791/74541 ↗At a glance
Journal article in Journal of Visualized Experiments, published online on 2026-11-13. Written by Simone Khalifeh and 6 co-authors.
Abstract (original language)
The autoimmune encephalitides (AE) are immune-mediated diseases of the central nervous system affecting children. This study from Lebanon describes the clinical presentations, treatments, and outcomes of antibody-positive autoimmune encephalitis in children. This is a retrospective study of children ≤ 18 years old with antibody-positive AE that presented to the American University of Beirut Medical Center (AUBMC) from January 2010 to October 2024. The Modified Rankin Scale (mRS) was used to assess outcomes, with scores of 0-2 indicating a good outcome and 3-5 indicating a poor outcome. Fisher's exact test was used to correlate outcome with categorical variables, including sex, geographic region, clinical presentation, cerebrospinal fluid (CSF) cell counts, brain imaging findings, antibody titers, time to treatment, first line treatment, second line treatment, and outcomes at 6 months follow-up, and Mann Whitney U test categorizing age as a continuous variable. Results: Seventeen patients were included. Detected antibodies were anti-myelin oligodendrocyte protein (MOG) (58.8%), N-methyl-D-aspartic acid (NMDA) receptor antibody (17.6%), neuromyelitis optica (NMO) aquaporin-4 (AQP4) antibodies (17.6%), and anti-glutamic acid decarboxylase (GAD) antibody (6%). Immunotherapy consisted of high-dose methylprednisolone, intravenous immunoglobulin (IVIG), and/or plasma exchange. Of patients with myelin oligodendrocyte antibody disease (MOGAD), 90% had a good outcome. Outcome was poor in 4/17 patients (23.5%). No variables were significantly correlated with the final outcome. Autoimmune encephalitis affects quality of life. These findings may increase awareness of pediatric AE and MOGAD in Lebanon and inform clinical recognition and management.
Cite
APA
Khalifeh, S., Trad, S., Hourani, R., Habanjar, D., Annan, T. E., Hnaini, M., & Boustany, R. (2026). Pediatric Seropositive Autoimmune Encephalitis: A Health Outcome Study. Journal of Visualized Experiments. https://doi.org/10.3791/74541
Vancouver
Khalifeh S, Trad S, Hourani R, Habanjar D, Annan TE, Hnaini M, et al. Pediatric Seropositive Autoimmune Encephalitis: A Health Outcome Study. Journal of Visualized Experiments. 2026. doi:10.3791/74541
BibTeX
@article{Khalifeh2026,
author = {Khalifeh, Simone and Trad, Samah and Hourani, Roula and Habanjar, Dima and Annan, Tamara El and Hnaini, Mona and Boustany, Rose-Mary},
title = {Pediatric Seropositive Autoimmune Encephalitis: A Health Outcome Study},
journal = {Journal of Visualized Experiments},
year = {2026},
number = {237},
doi = {10.3791/74541}
}
EUVIMED